ID   PYRD_HUMAN              Reviewed;         395 AA.
AC   Q02127; A8K8C8; Q6P176;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 3.
DT   18-JUN-2025, entry version 231.
DE   RecName: Full=Dihydroorotate dehydrogenase (quinone), mitochondrial;
DE            Short=DHOdehase;
DE            EC=1.3.5.2 {ECO:0000269|PubMed:8925840};
DE   AltName: Full=Dihydroorotate oxidase;
DE   Flags: Precursor;
GN   Name=DHODH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLN-7.
RX   PubMed=1446837; DOI=10.1016/0378-1119(92)90150-n;
RA   Minet M., Dufour M.E., Lacroute F.;
RT   "Cloning and sequencing of a human cDNA coding for dihydroorotate
RT   dehydrogenase by complementation of the corresponding yeast mutant.";
RL   Gene 121:393-396(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   PubMed=7487077; DOI=10.1006/abbi.1995.0012;
RA   Copeland R.A., Davis J.P., Dowling R.L., Lombardo D., Murphy K.B.,
RA   Patterson T.A.;
RT   "Recombinant human dihydroorotate dehydrogenase: expression, purification,
RT   and characterization of a catalytically functional truncated enzyme.";
RL   Arch. Biochem. Biophys. 323:79-86(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-7.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=8925840; DOI=10.1111/j.1432-1033.1996.0292h.x;
RA   Knecht W., Bergjohann U., Gonski S., Kirschbaum B., Loeffler M.;
RT   "Functional expression of a fragment of human dihydroorotate dehydrogenase
RT   by means of the baculovirus expression vector system, and kinetic
RT   investigation of the purified recombinant enzyme.";
RL   Eur. J. Biochem. 240:292-301(1996).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10727948; DOI=10.1046/j.1432-1327.2000.01213.x;
RA   Rawls J., Knecht W., Diekert K., Lill R., Loeffler M.;
RT   "Requirements for the mitochondrial import and localization of
RT   dihydroorotate dehydrogenase.";
RL   Eur. J. Biochem. 267:2079-2087(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 29-395 IN COMPLEX WITH FMN;
RP   DIHYDROOROTATE AND INHIBITORS, AND COFACTOR.
RX   PubMed=10673429; DOI=10.1016/s0969-2126(00)00077-0;
RA   Liu S., Neidhardt E.A., Grossman T.H., Ocain T., Clardy J.;
RT   "Structures of human dihydroorotate dehydrogenase in complex with
RT   antiproliferative agents.";
RL   Structure 8:25-33(2000).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 29-395 IN COMPLEX WITH FMN AND
RP   INHIBITORS.
RX   PubMed=16480261; DOI=10.1021/jm0506975;
RA   Baumgartner R., Walloschek M., Kralik M., Gotschlich A., Tasler S.,
RA   Mies J., Leban J.;
RT   "Dual binding mode of a novel series of DHODH inhibitors.";
RL   J. Med. Chem. 49:1239-1247(2006).
RN   [12]
RP   VARIANTS POADS GLU-19; CYS-135; ARG-152; CYS-199; ALA-202; ASP-202;
RP   TRP-244; ILE-284; TRP-346 AND GLY-392.
RX   PubMed=19915526; DOI=10.1038/ng.499;
RA   Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., Dent K.M.,
RA   Huff C.D., Shannon P.T., Jabs E.W., Nickerson D.A., Shendure J.,
RA   Bamshad M.J.;
RT   "Exome sequencing identifies the cause of a Mendelian disorder.";
RL   Nat. Genet. 42:30-35(2010).
CC   -!- FUNCTION: Catalyzes the conversion of dihydroorotate to orotate with
CC       quinone as electron acceptor. Required for UMP biosynthesis via de novo
CC       pathway. {ECO:0000269|PubMed:8925840}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-dihydroorotate + a quinone = orotate + a quinol;
CC         Xref=Rhea:RHEA:30187, ChEBI:CHEBI:24646, ChEBI:CHEBI:30839,
CC         ChEBI:CHEBI:30864, ChEBI:CHEBI:132124; EC=1.3.5.2;
CC         Evidence={ECO:0000269|PubMed:8925840};
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC         Evidence={ECO:0000269|PubMed:10673429};
CC       Note=Binds 1 FMN per subunit. {ECO:0000269|PubMed:10673429};
CC   -!- PATHWAY: Pyrimidine metabolism; UMP biosynthesis via de novo pathway;
CC       orotate from (S)-dihydroorotate (quinone route): step 1/1.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:10673429,
CC       ECO:0000269|PubMed:16480261}.
CC   -!- INTERACTION:
CC       Q02127; Q6ZMZ0: RNF19B; NbExp=3; IntAct=EBI-3928775, EBI-2466594;
CC       Q02127; P49638: TTPA; NbExp=3; IntAct=EBI-3928775, EBI-10210710;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:10727948}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:10727948}.
CC   -!- PTM: The uncleaved transit peptide is required for mitochondrial
CC       targeting and proper membrane integration.
CC   -!- DISEASE: Postaxial acrofacial dysostosis (POADS) [MIM:263750]: An
CC       autosomal recessive syndrome characterized by severe micrognathia,
CC       cleft lip and/or palate, hypoplasia or aplasia of the posterior
CC       elements of the limbs, coloboma of the eyelids and supernumerary
CC       nipples. {ECO:0000269|PubMed:19915526}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The identification of DHODH defects as the cause of
CC       postaxial acrofacial dysostosis (POADS) was obtained via exome
CC       sequencing (PubMed:19915526), demonstrating that this method is a
CC       powerful tool for identifying genes underlying rare Mendelian
CC       disorders. Exome sequencing consists of targeted resequencing of all
CC       protein-coding subsequences, which requires around 5% as much
CC       sequencing as a whole human genome. {ECO:0000305|PubMed:19915526}.
CC   -!- SIMILARITY: Belongs to the dihydroorotate dehydrogenase family. Type 2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94065; AAA50163.1; -; mRNA.
DR   EMBL; AK292293; BAF84982.1; -; mRNA.
DR   EMBL; BC065245; AAH65245.1; -; mRNA.
DR   CCDS; CCDS42192.1; -.
DR   PIR; PC1219; PC1219.
DR   RefSeq; NP_001352.2; NM_001361.4.
DR   PDB; 1D3G; X-ray; 1.60 A; A=29-395.
DR   PDB; 1D3H; X-ray; 1.80 A; A=29-395.
DR   PDB; 2B0M; X-ray; 2.00 A; A=29-395.
DR   PDB; 2BXV; X-ray; 2.15 A; A=29-395.
DR   PDB; 2FPT; X-ray; 2.40 A; A=29-395.
DR   PDB; 2FPV; X-ray; 1.80 A; A=29-395.
DR   PDB; 2FPY; X-ray; 2.00 A; A=29-395.
DR   PDB; 2FQI; X-ray; 1.95 A; A=29-395.
DR   PDB; 2PRH; X-ray; 2.40 A; A=29-395.
DR   PDB; 2PRL; X-ray; 2.10 A; A=29-395.
DR   PDB; 2PRM; X-ray; 3.00 A; A=29-395.
DR   PDB; 2WV8; X-ray; 1.90 A; A=31-395.
DR   PDB; 3F1Q; X-ray; 2.00 A; A=29-395.
DR   PDB; 3FJ6; X-ray; 1.80 A; A=29-395.
DR   PDB; 3FJL; X-ray; 1.90 A; A=29-395.
DR   PDB; 3G0U; X-ray; 2.00 A; A=29-395.
DR   PDB; 3G0X; X-ray; 1.80 A; A=29-395.
DR   PDB; 3KVJ; X-ray; 1.94 A; A=29-395.
DR   PDB; 3KVK; X-ray; 2.05 A; A=29-395.
DR   PDB; 3KVL; X-ray; 1.85 A; A=29-395.
DR   PDB; 3KVM; X-ray; 2.00 A; A=29-395.
DR   PDB; 3U2O; X-ray; 2.18 A; A=1-395.
DR   PDB; 3W7R; X-ray; 1.68 A; A=29-395.
DR   PDB; 3ZWS; X-ray; 1.60 A; A=29-395.
DR   PDB; 3ZWT; X-ray; 1.55 A; A=29-395.
DR   PDB; 4IGH; X-ray; 1.30 A; A=32-395.
DR   PDB; 4JGD; X-ray; 2.05 A; A=29-395.
DR   PDB; 4JS3; X-ray; 2.00 A; A=29-395.
DR   PDB; 4JTS; X-ray; 2.21 A; A=29-395.
DR   PDB; 4JTT; X-ray; 2.10 A; A=29-395.
DR   PDB; 4JTU; X-ray; 1.90 A; A=29-395.
DR   PDB; 4LS0; X-ray; 2.07 A; A=29-395.
DR   PDB; 4LS1; X-ray; 2.20 A; A=29-395.
DR   PDB; 4LS2; X-ray; 2.27 A; A=29-395.
DR   PDB; 4OQV; X-ray; 1.23 A; A=32-395.
DR   PDB; 4RK8; X-ray; 2.22 A; A=29-395.
DR   PDB; 4RKA; X-ray; 2.71 A; A=29-395.
DR   PDB; 4RLI; X-ray; 2.50 A; A=29-395.
DR   PDB; 4RR4; X-ray; 2.38 A; A=29-395.
DR   PDB; 4YLW; X-ray; 1.79 A; A=29-395.
DR   PDB; 4ZL1; X-ray; 1.86 A; A=29-395.
DR   PDB; 4ZMG; X-ray; 1.90 A; A=29-395.
DR   PDB; 5H2Z; X-ray; 1.58 A; A=29-395.
DR   PDB; 5H73; X-ray; 1.58 A; A=29-395.
DR   PDB; 5HIN; X-ray; 1.60 A; A=29-395.
DR   PDB; 5HQE; X-ray; 1.62 A; A=29-395.
DR   PDB; 5K9C; X-ray; 1.66 A; A=29-395.
DR   PDB; 5K9D; X-ray; 1.70 A; A=29-395.
DR   PDB; 5MUT; X-ray; 1.75 A; A=31-395.
DR   PDB; 5MVC; X-ray; 1.85 A; A=29-395.
DR   PDB; 5MVD; X-ray; 1.95 A; A=33-395.
DR   PDB; 5TCE; NMR; -; A=32-65.
DR   PDB; 5ZF4; X-ray; 1.66 A; A=29-395.
DR   PDB; 5ZF7; X-ray; 1.79 A; A=29-395.
DR   PDB; 5ZF8; X-ray; 1.70 A; A=29-395.
DR   PDB; 5ZF9; X-ray; 1.77 A; A=29-395.
DR   PDB; 5ZFA; X-ray; 1.75 A; A=29-395.
DR   PDB; 5ZFB; X-ray; 2.00 A; A=29-395.
DR   PDB; 6CJF; X-ray; 1.63 A; A/B=32-395.
DR   PDB; 6CJG; X-ray; 2.85 A; A=32-395.
DR   PDB; 6ET4; X-ray; 1.70 A; A=29-395.
DR   PDB; 6FMD; X-ray; 1.58 A; A=1-395.
DR   PDB; 6GK0; X-ray; 1.85 A; A=29-395.
DR   PDB; 6IDJ; X-ray; 1.90 A; A=29-395.
DR   PDB; 6J3B; X-ray; 1.60 A; A=30-395.
DR   PDB; 6J3C; X-ray; 1.85 A; A=30-395.
DR   PDB; 6JMD; X-ray; 1.78 A; A=30-395.
DR   PDB; 6JME; X-ray; 1.80 A; A=30-395.
DR   PDB; 6LP6; X-ray; 1.79 A; A=30-395.
DR   PDB; 6LP7; X-ray; 1.80 A; A=30-395.
DR   PDB; 6LP8; X-ray; 1.79 A; A=30-395.
DR   PDB; 6LZL; X-ray; 1.98 A; A=31-395.
DR   PDB; 6M2B; X-ray; 1.76 A; A=29-395.
DR   PDB; 6OC0; X-ray; 1.40 A; A=29-395.
DR   PDB; 6OC1; X-ray; 2.70 A; A=29-395.
DR   PDB; 6QU7; X-ray; 1.52 A; A=30-395.
DR   PDB; 6SYP; X-ray; 1.80 A; AAA=1-395.
DR   PDB; 6VND; X-ray; 1.97 A; A=29-395.
DR   PDB; 7K2U; X-ray; 1.73 A; A=29-395.
DR   PDB; 7Z6C; X-ray; 1.85 A; A=30-395.
DR   PDB; 8DHF; X-ray; 1.78 A; A=29-395.
DR   PDB; 8DHG; X-ray; 1.85 A; A=29-395.
DR   PDB; 8DHH; X-ray; 2.02 A; A=29-395.
DR   PDB; 8K4F; X-ray; 2.48 A; A=30-395.
DR   PDB; 8RAK; X-ray; 1.85 A; A=29-395.
DR   PDB; 8VHL; X-ray; 1.93 A; A=29-395.
DR   PDB; 8VHM; X-ray; 2.26 A; A=29-395.
DR   PDB; 8YHR; X-ray; 1.70 A; A=29-395.
DR   PDB; 9BKM; X-ray; 2.08 A; A=29-395.
DR   PDB; 9BKN; X-ray; 1.30 A; A=30-395.
DR   PDB; 9BKO; X-ray; 1.44 A; A=30-395.
DR   PDB; 9DHG; X-ray; 1.39 A; A=29-395.
DR   PDB; 9DHH; X-ray; 1.49 A; A=29-395.
DR   PDB; 9DHI; X-ray; 1.38 A; A=29-395.
DR   PDB; 9DHJ; X-ray; 1.40 A; A=29-395.
DR   PDB; 9I2Y; X-ray; 1.95 A; A=31-395.
DR   PDBsum; 1D3G; -.
DR   PDBsum; 1D3H; -.
DR   PDBsum; 2B0M; -.
DR   PDBsum; 2BXV; -.
DR   PDBsum; 2FPT; -.
DR   PDBsum; 2FPV; -.
DR   PDBsum; 2FPY; -.
DR   PDBsum; 2FQI; -.
DR   PDBsum; 2PRH; -.
DR   PDBsum; 2PRL; -.
DR   PDBsum; 2PRM; -.
DR   PDBsum; 2WV8; -.
DR   PDBsum; 3F1Q; -.
DR   PDBsum; 3FJ6; -.
DR   PDBsum; 3FJL; -.
DR   PDBsum; 3G0U; -.
DR   PDBsum; 3G0X; -.
DR   PDBsum; 3KVJ; -.
DR   PDBsum; 3KVK; -.
DR   PDBsum; 3KVL; -.
DR   PDBsum; 3KVM; -.
DR   PDBsum; 3U2O; -.
DR   PDBsum; 3W7R; -.
DR   PDBsum; 3ZWS; -.
DR   PDBsum; 3ZWT; -.
DR   PDBsum; 4IGH; -.
DR   PDBsum; 4JGD; -.
DR   PDBsum; 4JS3; -.
DR   PDBsum; 4JTS; -.
DR   PDBsum; 4JTT; -.
DR   PDBsum; 4JTU; -.
DR   PDBsum; 4LS0; -.
DR   PDBsum; 4LS1; -.
DR   PDBsum; 4LS2; -.
DR   PDBsum; 4OQV; -.
DR   PDBsum; 4RK8; -.
DR   PDBsum; 4RKA; -.
DR   PDBsum; 4RLI; -.
DR   PDBsum; 4RR4; -.
DR   PDBsum; 4YLW; -.
DR   PDBsum; 4ZL1; -.
DR   PDBsum; 4ZMG; -.
DR   PDBsum; 5H2Z; -.
DR   PDBsum; 5H73; -.
DR   PDBsum; 5HIN; -.
DR   PDBsum; 5HQE; -.
DR   PDBsum; 5K9C; -.
DR   PDBsum; 5K9D; -.
DR   PDBsum; 5MUT; -.
DR   PDBsum; 5MVC; -.
DR   PDBsum; 5MVD; -.
DR   PDBsum; 5TCE; -.
DR   PDBsum; 5ZF4; -.
DR   PDBsum; 5ZF7; -.
DR   PDBsum; 5ZF8; -.
DR   PDBsum; 5ZF9; -.
DR   PDBsum; 5ZFA; -.
DR   PDBsum; 5ZFB; -.
DR   PDBsum; 6CJF; -.
DR   PDBsum; 6CJG; -.
DR   PDBsum; 6ET4; -.
DR   PDBsum; 6FMD; -.
DR   PDBsum; 6GK0; -.
DR   PDBsum; 6IDJ; -.
DR   PDBsum; 6J3B; -.
DR   PDBsum; 6J3C; -.
DR   PDBsum; 6JMD; -.
DR   PDBsum; 6JME; -.
DR   PDBsum; 6LP6; -.
DR   PDBsum; 6LP7; -.
DR   PDBsum; 6LP8; -.
DR   PDBsum; 6LZL; -.
DR   PDBsum; 6M2B; -.
DR   PDBsum; 6OC0; -.
DR   PDBsum; 6OC1; -.
DR   PDBsum; 6QU7; -.
DR   PDBsum; 6SYP; -.
DR   PDBsum; 6VND; -.
DR   PDBsum; 7K2U; -.
DR   PDBsum; 7Z6C; -.
DR   PDBsum; 8DHF; -.
DR   PDBsum; 8DHG; -.
DR   PDBsum; 8DHH; -.
DR   PDBsum; 8K4F; -.
DR   PDBsum; 8RAK; -.
DR   PDBsum; 8VHL; -.
DR   PDBsum; 8VHM; -.
DR   PDBsum; 8YHR; -.
DR   PDBsum; 9BKM; -.
DR   PDBsum; 9BKN; -.
DR   PDBsum; 9BKO; -.
DR   PDBsum; 9DHG; -.
DR   PDBsum; 9DHH; -.
DR   PDBsum; 9DHI; -.
DR   PDBsum; 9DHJ; -.
DR   PDBsum; 9I2Y; -.
DR   AlphaFoldDB; Q02127; -.
DR   SMR; Q02127; -.
DR   BioGRID; 108068; 46.
DR   FunCoup; Q02127; 2176.
DR   IntAct; Q02127; 16.
DR   STRING; 9606.ENSP00000219240; -.
DR   BindingDB; Q02127; -.
DR   ChEMBL; CHEMBL1966; -.
DR   DrugBank; DB07559; (2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide.
DR   DrugBank; DB07561; (2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide.
DR   DrugBank; DB08172; (2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide.
DR   DrugBank; DB08169; (2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide.
DR   DrugBank; DB07443; (2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide.
DR   DrugBank; DB07978; 2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID.
DR   DrugBank; DB07975; 2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID.
DR   DrugBank; DB04281; 2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone.
DR   DrugBank; DB08249; 3,6,9,12,15-PENTAOXATRICOSAN-1-OL.
DR   DrugBank; DB07977; 3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID.
DR   DrugBank; DB07976; 3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID.
DR   DrugBank; DB04583; 5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid.
DR   DrugBank; DB08008; 5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine.
DR   DrugBank; DB01117; Atovaquone.
DR   DrugBank; DB03523; Brequinar.
DR   DrugBank; DB03480; Brequinar Analog.
DR   DrugBank; DB02613; Capric dimethyl amine oxide.
DR   DrugBank; DB04147; Dodecyldimethylamine N-oxide.
DR   DrugBank; DB03247; Flavin mononucleotide.
DR   DrugBank; DB01097; Leflunomide.
DR   DrugBank; DB06481; Manitimus.
DR   DrugBank; DB08006; N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine.
DR   DrugBank; DB02262; Orotic acid.
DR   DrugBank; DB05125; SC12267.
DR   DrugBank; DB08880; Teriflunomide.
DR   DrugBank; DB07646; UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE.
DR   DrugBank; DB15446; Vidofludimus.
DR   DrugCentral; Q02127; -.
DR   GuidetoPHARMACOLOGY; 2604; -.
DR   GlyGen; Q02127; 1 site, 1 N-linked glycan (1 site).
DR   iPTMnet; Q02127; -.
DR   PhosphoSitePlus; Q02127; -.
DR   SwissPalm; Q02127; -.
DR   BioMuta; DHODH; -.
DR   DMDM; 56405372; -.
DR   jPOST; Q02127; -.
DR   MassIVE; Q02127; -.
DR   PaxDb; 9606-ENSP00000219240; -.
DR   PeptideAtlas; Q02127; -.
DR   ProteomicsDB; 58051; -.
DR   Pumba; Q02127; -.
DR   TopDownProteomics; Q02127; -.
DR   Antibodypedia; 2311; 335 antibodies from 35 providers.
DR   DNASU; 1723; -.
DR   Ensembl; ENST00000219240.9; ENSP00000219240.4; ENSG00000102967.12.
DR   GeneID; 1723; -.
DR   KEGG; hsa:1723; -.
DR   MANE-Select; ENST00000219240.9; ENSP00000219240.4; NM_001361.5; NP_001352.2.
DR   UCSC; uc002fbp.4; human.
DR   AGR; HGNC:2867; -.
DR   CTD; 1723; -.
DR   DisGeNET; 1723; -.
DR   GeneCards; DHODH; -.
DR   HGNC; HGNC:2867; DHODH.
DR   HPA; ENSG00000102967; Tissue enriched (liver).
DR   MalaCards; DHODH; -.
DR   MIM; 126064; gene.
DR   MIM; 263750; phenotype.
DR   OpenTargets; ENSG00000102967; -.
DR   Orphanet; 246; Postaxial acrofacial dysostosis.
DR   VEuPathDB; HostDB:ENSG00000102967; -.
DR   eggNOG; KOG1436; Eukaryota.
DR   GeneTree; ENSGT00500000044924; -.
DR   InParanoid; Q02127; -.
DR   OMA; ERIKMGA; -.
DR   OrthoDB; 14784at2759; -.
DR   PAN-GO; Q02127; 4 GO annotations based on evolutionary models.
DR   PhylomeDB; Q02127; -.
DR   BRENDA; 1.3.5.2; 2681.
DR   PathwayCommons; Q02127; -.
DR   Reactome; R-HSA-500753; Pyrimidine biosynthesis.
DR   SABIO-RK; Q02127; -.
DR   SignaLink; Q02127; -.
DR   SIGNOR; Q02127; -.
DR   UniPathway; UPA00070; UER00946.
DR   BioGRID-ORCS; 1723; 293 hits in 1178 CRISPR screens.
DR   ChiTaRS; DHODH; human.
DR   EvolutionaryTrace; Q02127; -.
DR   GenomeRNAi; 1723; -.
DR   Pharos; Q02127; Tclin.
DR   PRO; PR:Q02127; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q02127; protein.
DR   Bgee; ENSG00000102967; Expressed in right lobe of liver and 109 other cell types or tissues.
DR   ExpressionAtlas; Q02127; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004151; F:dihydroorotase activity; IEA:Ensembl.
DR   GO; GO:0106430; F:dihydroorotate dehydrogenase (quinone) activity; IDA:FlyBase.
DR   GO; GO:0004152; F:dihydroorotate dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0006207; P:'de novo' pyrimidine nucleobase biosynthetic process; IBA:GO_Central.
DR   GO; GO:0044205; P:'de novo' UMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009220; P:pyrimidine ribonucleotide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006225; P:UDP biosynthetic process; IEA:Ensembl.
DR   CDD; cd04738; DHOD_2_like; 1.
DR   FunFam; 3.20.20.70:FF:000066; Dihydroorotate dehydrogenase (quinone), mitochondrial; 1.
DR   Gene3D; 3.20.20.70; Aldolase class I; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR050074; DHO_dehydrogenase.
DR   InterPro; IPR005719; Dihydroorotate_DH_2.
DR   InterPro; IPR005720; Dihydroorotate_DH_cat.
DR   InterPro; IPR001295; Dihydroorotate_DH_CS.
DR   NCBIfam; NF003645; PRK05286.1-2; 1.
DR   NCBIfam; NF003652; PRK05286.2-5; 1.
DR   NCBIfam; TIGR01036; pyrD_sub2; 1.
DR   PANTHER; PTHR48109:SF4; DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL; 1.
DR   PANTHER; PTHR48109; DIHYDROOROTATE DEHYDROGENASE (QUINONE), MITOCHONDRIAL-RELATED; 1.
DR   Pfam; PF01180; DHO_dh; 1.
DR   SUPFAM; SSF51395; FMN-linked oxidoreductases; 1.
DR   PROSITE; PS00911; DHODEHASE_1; 1.
DR   PROSITE; PS00912; DHODEHASE_2; 1.
DR   neXtProt; NX_Q02127; -.
DR   PharmGKB; PA27327; -.
DR   TreeFam; TF105973; -.
PE   1: Evidence at protein level;
KW   3D-structure; Disease variant; Flavoprotein; FMN; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Oxidoreductase; Proteomics identification;
KW   Pyrimidine biosynthesis; Reference proteome; Transit peptide;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..395
FT                   /note="Dihydroorotate dehydrogenase (quinone),
FT                   mitochondrial"
FT                   /id="PRO_0000029884"
FT   TRANSIT         1..10
FT                   /note="Mitochondrion; not cleaved"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        1..10
FT                   /note="Mitochondrial matrix"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        11..30
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        31..395
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        214
FT                   /note="Nucleophile"
FT   BINDING         95..99
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         99
FT                   /ligand="substrate"
FT   BINDING         119
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         144..148
FT                   /ligand="substrate"
FT   BINDING         180
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         211..216
FT                   /ligand="substrate"
FT   BINDING         211
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         254
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         282
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         283..284
FT                   /ligand="substrate"
FT   BINDING         305
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         334
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   BINDING         355..356
FT                   /ligand="FMN"
FT                   /ligand_id="ChEBI:CHEBI:58210"
FT                   /evidence="ECO:0000269|PubMed:10673429,
FT                   ECO:0000269|PubMed:16480261"
FT   VARIANT         7
FT                   /note="K -> Q (in dbSNP:rs3213422)"
FT                   /evidence="ECO:0000269|PubMed:1446837,
FT                   ECO:0000269|PubMed:14702039"
FT                   /id="VAR_022094"
FT   VARIANT         19
FT                   /note="G -> E (in POADS; dbSNP:rs267606765)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062412"
FT   VARIANT         135
FT                   /note="R -> C (in POADS; dbSNP:rs201230446)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062413"
FT   VARIANT         152
FT                   /note="G -> R (in POADS; dbSNP:rs267606766)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062414"
FT   VARIANT         199
FT                   /note="R -> C (in POADS; dbSNP:rs267606769)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062415"
FT   VARIANT         202
FT                   /note="G -> A (in POADS; dbSNP:rs267606767)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062416"
FT   VARIANT         202
FT                   /note="G -> D (in POADS; dbSNP:rs267606767)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062417"
FT   VARIANT         244
FT                   /note="R -> W (in POADS; dbSNP:rs267606768)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062418"
FT   VARIANT         284
FT                   /note="T -> I (in POADS)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062419"
FT   VARIANT         346
FT                   /note="R -> W (in POADS; dbSNP:rs201947120)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062420"
FT   VARIANT         392
FT                   /note="D -> G (in POADS; dbSNP:rs779076692)"
FT                   /evidence="ECO:0000269|PubMed:19915526"
FT                   /id="VAR_062421"
FT   CONFLICT        1..2
FT                   /note="MA -> KLP (in Ref. 1; AAA50163)"
FT                   /evidence="ECO:0000305"
FT   HELIX           34..39
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           41..48
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           51..63
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           76..78
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          85..93
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   TURN            95..100
FT                   /evidence="ECO:0007829|PDB:6OC0"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:6OC0"
FT   HELIX           104..109
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          113..120
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          133..136
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           137..139
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          141..144
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           153..161
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           164..172
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          177..181
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           190..201
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           202..204
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          206..212
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          215..217
FT                   /evidence="ECO:0007829|PDB:6OC1"
FT   TURN            218..221
FT                   /evidence="ECO:0007829|PDB:6QU7"
FT   HELIX           226..241
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           245..247
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           261..274
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          278..281
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          285..287
FT                   /evidence="ECO:0007829|PDB:5K9C"
FT   TURN            295..298
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          299..305
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           306..308
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           309..322
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   TURN            323..325
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          329..334
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           338..347
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   STRAND          349..355
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           356..361
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           364..379
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           385..388
FT                   /evidence="ECO:0007829|PDB:4OQV"
FT   HELIX           391..393
FT                   /evidence="ECO:0007829|PDB:4OQV"
SQ   SEQUENCE   395 AA;  42867 MW;  072C3169E78C6440 CRC64;
     MAWRHLKKRA QDAVIILGGG GLLFASYLMA TGDERFYAEH LMPTLQGLLD PESAHRLAVR
     FTSLGLLPRA RFQDSDMLEV RVLGHKFRNP VGIAAGFDKH GEAVDGLYKM GFGFVEIGSV
     TPKPQEGNPR PRVFRLPEDQ AVINRYGFNS HGLSVVEHRL RARQQKQAKL TEDGLPLGVN
     LGKNKTSVDA AEDYAEGVRV LGPLADYLVV NVSSPNTAGL RSLQGKAELR RLLTKVLQER
     DGLRRVHRPA VLVKIAPDLT SQDKEDIASV VKELGIDGLI VTNTTVSRPA GLQGALRSET
     GGLSGKPLRD LSTQTIREMY ALTQGRVPII GVGGVSSGQD ALEKIRAGAS LVQLYTALTF
     WGPPVVGKVK RELEALLKEQ GFGGVTDAIG ADHRR
//
